These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 15240532)
1. The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients. Gifford G; Paul J; Vasey PA; Kaye SB; Brown R Clin Cancer Res; 2004 Jul; 10(13):4420-6. PubMed ID: 15240532 [TBL] [Abstract][Full Text] [Related]
3. Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemia. Seedhouse CH; Das-Gupta EP; Russell NH Leukemia; 2003 Jan; 17(1):83-8. PubMed ID: 12529664 [TBL] [Abstract][Full Text] [Related]
4. High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas. Strazzullo M; Cossu A; Baldinu P; Colombino M; Satta MP; Tanda F; De Bonis ML; Cerase A; D'Urso M; D'Esposito M; Palmieri G Cancer; 2003 Oct; 98(7):1540-6. PubMed ID: 14508843 [TBL] [Abstract][Full Text] [Related]
5. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Deng G; Chen A; Hong J; Chae HS; Kim YS Cancer Res; 1999 May; 59(9):2029-33. PubMed ID: 10232580 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of promoter methylation and altered expression of hMLH1 in gastric cancer cell lines with microsatellite instability. Kang YH; Bae SI; Kim WH J Cancer Res Clin Oncol; 2002 Mar; 128(3):119-24. PubMed ID: 11935297 [TBL] [Abstract][Full Text] [Related]
7. Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy. Samimi G; Fink D; Varki NM; Husain A; Hoskins WJ; Alberts DS; Howell SB Clin Cancer Res; 2000 Apr; 6(4):1415-21. PubMed ID: 10778972 [TBL] [Abstract][Full Text] [Related]
8. Influence of hMLH1 methylation, mismatch repair deficiency and microsatellite instability on chemoresistance of testicular germ-cell tumors. Olasz J; Mándoky L; Géczi L; Bodrogi I; Csuka O; Bak M Anticancer Res; 2005; 25(6B):4319-24. PubMed ID: 16309235 [TBL] [Abstract][Full Text] [Related]
9. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. Fleisher AS; Esteller M; Harpaz N; Leytin A; Rashid A; Xu Y; Liang J; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Wilson KT; James SP; Herman JG; Meltzer SJ Cancer Res; 2000 Sep; 60(17):4864-8. PubMed ID: 10987299 [TBL] [Abstract][Full Text] [Related]
10. Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter. Plumb JA; Strathdee G; Sludden J; Kaye SB; Brown R Cancer Res; 2000 Nov; 60(21):6039-44. PubMed ID: 11085525 [TBL] [Abstract][Full Text] [Related]
11. Defective mismatch repair and the development of recurrent endometrial carcinoma. Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202 [TBL] [Abstract][Full Text] [Related]
12. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas. Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754 [TBL] [Abstract][Full Text] [Related]
13. [Hypermethylation of hMLH1 and microsatellite instability in ovarian mucinous tumors]. Chen HZ; Ye DF; Xie X; Hu M; Lu WG Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):457-61. PubMed ID: 12974095 [TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of the hMLH1 gene promoter in solitary and multiple gastric cancers with microsatellite instability. Sakata K; Tamura G; Endoh Y; Ohmura K; Ogata S; Motoyama T Br J Cancer; 2002 Feb; 86(4):564-7. PubMed ID: 11870538 [TBL] [Abstract][Full Text] [Related]
15. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Lee JH; Park SJ; Abraham SC; Seo JS; Nam JH; Choi C; Juhng SW; Rashid A; Hamilton SR; Wu TT Oncogene; 2004 Jun; 23(26):4646-54. PubMed ID: 15064707 [TBL] [Abstract][Full Text] [Related]
16. Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer. Fox EJ; Leahy DT; Geraghty R; Mulcahy HE; Fennelly D; Hyland JM; O'Donoghue DP; Sheahan K J Mol Diagn; 2006 Feb; 8(1):68-75. PubMed ID: 16436636 [TBL] [Abstract][Full Text] [Related]
17. [Methylation of hMLH1 gene promoter in gastric carcinoma with microsatellite instability]. Li JH; Shi XZ; Liu M; Wang Y; Yu ZH; Xu GW; Lu S Ai Zheng; 2005 Mar; 24(3):273-7. PubMed ID: 15757526 [TBL] [Abstract][Full Text] [Related]
18. Methylation in hMLH1 promoter interferes with its binding to transcription factor CBF and inhibits gene expression. Deng G; Chen A; Pong E; Kim YS Oncogene; 2001 Oct; 20(48):7120-7. PubMed ID: 11704838 [TBL] [Abstract][Full Text] [Related]
19. Methylation of hMLH1 in a population-based series of endometrial carcinomas. Salvesen HB; MacDonald N; Ryan A; Iversen OE; Jacobs IJ; Akslen LA; Das S Clin Cancer Res; 2000 Sep; 6(9):3607-13. PubMed ID: 10999752 [TBL] [Abstract][Full Text] [Related]
20. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. Arnold CN; Goel A; Boland CR Int J Cancer; 2003 Aug; 106(1):66-73. PubMed ID: 12794758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]